User: Guest

HEMATOLOGICAL MALIGNANCIES

Global Market Trajectory & Analytics

MCP16456

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

4443
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

802
Interactions with Platform & by Email

PARTICIPANTS

133
Unique # Participated

VALIDATIONS

61
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

108

PAGES

182

EDITION

6

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for Hematological Malignancies estimated at US$35.5 Billion in the year 2020, is projected to reach a revised size of US$53.8 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Leukemia, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$22.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Lymphoma segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
The Hematological Malignancies market in the U.S. is estimated at US$10.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.4 Billion by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
In the global Myeloma segment, USA, Canada, Japan, China and Europe will drive the 5.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.7 Billion in the year 2020 will reach a projected size of US$9.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.2 Billion by the year 2027.We bring years of research experience to this 6th edition of our report. The 182-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
AbbVie, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Johnson & Johnson; Novartis AG; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.
» Disease Condition (Leukemia, Lymphoma, Myeloma, Other Disease Conditions) » Therapy (Chemotherapy, Immunotherapy, Targeted Therapy)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Hematological Malignancies Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Hematological Malignancies Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Hematological Malignancies Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Hematological Malignancies Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Chemotherapy (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025
Chemotherapy (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Chemotherapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Immunotherapy (Therapy) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
Immunotherapy (Therapy) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
Immunotherapy (Therapy) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
Targeted Therapy (Therapy) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
Targeted Therapy (Therapy) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
Targeted Therapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Leukemia (Disease Condition) World Market by Region/Country in US$ Million: 2018 to 2025
Leukemia (Disease Condition) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Leukemia (Disease Condition) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Lymphoma (Disease Condition) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Lymphoma (Disease Condition) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Lymphoma (Disease Condition) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Myeloma (Disease Condition) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Myeloma (Disease Condition) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
Myeloma (Disease Condition) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Other Disease Conditions (Disease Condition) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
Other Disease Conditions (Disease Condition) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
Other Disease Conditions (Disease Condition) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Hematological Malignancies Market Share (in %) by Company: 2019 & 2025
United States Hematological Malignancies Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
Hematological Malignancies Market in the United States by Therapy: A Historic Review in US$ Million for 2009-2017
United States Hematological Malignancies Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
United States Hematological Malignancies Market Estimates and Projections in US$ Million by Disease Condition: 2018 to 2025
Hematological Malignancies Market in the United States by Disease Condition: A Historic Review in US$ Million for 2009-2017
United States Hematological Malignancies Market Share Breakdown by Disease Condition: 2009 VS 2019 VS 2025
CANADA
Canadian Hematological Malignancies Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
Canadian Hematological Malignancies Historic Market Review by Therapy in US$ Million: 2009-2017
Hematological Malignancies Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
Canadian Hematological Malignancies Market Estimates and Forecasts in US$ Million by Disease Condition: 2018 to 2025
Canadian Hematological Malignancies Historic Market Review by Disease Condition in US$ Million: 2009-2017
Hematological Malignancies Market in Canada: Percentage Share Breakdown of Sales by Disease Condition for 2009, 2019, and 2025
JAPAN
Japanese Market for Hematological Malignancies: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
Hematological Malignancies Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
Japanese Hematological Malignancies Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
Japanese Market for Hematological Malignancies: Annual Sales Estimates and Projections in US$ Million by Disease Condition for the Period 2018-2025
Hematological Malignancies Market in Japan: Historic Sales Analysis in US$ Million by Disease Condition for the Period 2009-2017
Japanese Hematological Malignancies Market Share Analysis by Disease Condition: 2009 VS 2019 VS 2025
CHINA
Chinese Hematological Malignancies Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
Hematological Malignancies Historic Market Analysis in China in US$ Million by Therapy: 2009-2017
Chinese Hematological Malignancies Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
Chinese Hematological Malignancies Market Growth Prospects in US$ Million by Disease Condition for the Period 2018-2025
Hematological Malignancies Historic Market Analysis in China in US$ Million by Disease Condition: 2009-2017
Chinese Hematological Malignancies Market by Disease Condition: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Hematological Malignancies Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Hematological Malignancies Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Hematological Malignancies Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Hematological Malignancies Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Hematological Malignancies Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
Hematological Malignancies Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
European Hematological Malignancies Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
European Hematological Malignancies Market Estimates and Forecasts in US$ Million by Disease Condition: 2018-2025
Hematological Malignancies Market in Europe in US$ Million by Disease Condition: A Historic Review for the Period 2009-2017
European Hematological Malignancies Market Share Breakdown by Disease Condition: 2009 VS 2019 VS 2025
FRANCE
Hematological Malignancies Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
French Hematological Malignancies Historic Market Scenario in US$ Million by Therapy: 2009-2017
French Hematological Malignancies Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
Hematological Malignancies Market in France by Disease Condition: Estimates and Projections in US$ Million for the Period 2018-2025
French Hematological Malignancies Historic Market Scenario in US$ Million by Disease Condition: 2009-2017
French Hematological Malignancies Market Share Analysis by Disease Condition: 2009 VS 2019 VS 2025
GERMANY
Hematological Malignancies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
German Hematological Malignancies Historic Market Analysis in US$ Million by Therapy: 2009-2017
German Hematological Malignancies Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
Hematological Malignancies Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease Condition for the Period 2018-2025
German Hematological Malignancies Historic Market Analysis in US$ Million by Disease Condition: 2009-2017
German Hematological Malignancies Market Share Breakdown by Disease Condition: 2009 VS 2019 VS 2025
ITALY
Italian Hematological Malignancies Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
Hematological Malignancies Historic Market Analysis in Italy in US$ Million by Therapy: 2009-2017
Italian Hematological Malignancies Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
Italian Hematological Malignancies Market Growth Prospects in US$ Million by Disease Condition for the Period 2018-2025
Hematological Malignancies Historic Market Analysis in Italy in US$ Million by Disease Condition: 2009-2017
Italian Hematological Malignancies Market by Disease Condition: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
United Kingdom Market for Hematological Malignancies: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
Hematological Malignancies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
United Kingdom Hematological Malignancies Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
United Kingdom Market for Hematological Malignancies: Annual Sales Estimates and Projections in US$ Million by Disease Condition for the Period 2018-2025
Hematological Malignancies Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease Condition for the Period 2009-2017
United Kingdom Hematological Malignancies Market Share Analysis by Disease Condition: 2009 VS 2019 VS 2025
REST OF EUROPE
Rest of Europe Hematological Malignancies Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
Hematological Malignancies Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
Rest of Europe Hematological Malignancies Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
Rest of Europe Hematological Malignancies Market Estimates and Forecasts in US$ Million by Disease Condition: 2018-2025
Hematological Malignancies Market in Rest of Europe in US$ Million by Disease Condition: A Historic Review for the Period 2009-2017
Rest of Europe Hematological Malignancies Market Share Breakdown by Disease Condition: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Hematological Malignancies Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Hematological Malignancies Historic Market Scenario in US$ Million by Therapy: 2009-2017
Asia-Pacific Hematological Malignancies Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
Hematological Malignancies Market in Asia-Pacific by Disease Condition: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Hematological Malignancies Historic Market Scenario in US$ Million by Disease Condition: 2009-2017
Asia-Pacific Hematological Malignancies Market Share Analysis by Disease Condition: 2009 VS 2019 VS 2025
REST OF WORLD
Rest of World Hematological Malignancies Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
Rest of World Hematological Malignancies Historic Market Review by Therapy in US$ Million: 2009-2017
Hematological Malignancies Market in Rest of World: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
Rest of World Hematological Malignancies Market Estimates and Forecasts in US$ Million by Disease Condition: 2018 to 2025
Rest of World Hematological Malignancies Historic Market Review by Disease Condition in US$ Million: 2009-2017
Hematological Malignancies Market in Rest of World: Percentage Share Breakdown of Sales by Disease Condition for 2009, 2019, and 2025
Total Companies Profiled : 5

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com